Australian Clinical Labs Limited (ASX:ACL) Share Market Overview and Healthcare Sector Profile

Anjali Anand

11 August 2026 11:19 PM AEST

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Australian Clinical Labs Limited (ASX:ACL) shares traded at $2.410 during the latest trading session.
The company recorded a daily share price increase of 2.118%, with trading Volume of 468,347 shares.
Australian Clinical Labs Limited recorded a Market Capitalisation of $440.18M.
The stock traded within a daily range of $2.350 to $2.410.
ACL shares recorded a 52-week trading range between $1.832 and $2.970.

Australian Clinical Labs Limited (ASX:ACL) Market Overview

Australian Clinical Labs Limited (ASX:ACL) is an Australian Securities Exchange-listed company operating within the health care equipment and services industry group.

The company’s shares were trading at $2.410, recording a daily movement of +2.118%. This article provides an educational overview of Australian Clinical Labs’ market information, including share price movement, trading activity, market capitalisation and key share statistics.

Share Price Movement and Trading Activity

Australian Clinical Labs Limited recorded a share price of $2.410 during the latest trading session, compared with the previous close of $2.360. The stock increased by $0.050, representing a daily movement of 2.118%.

During the session, ACL shares traded within a range of $2.350 to $2.410. The company recorded trading volume of 468,347 shares, while the average trading volume was 592,035 shares.

Trading volume represents the number of shares exchanged during a Trading session and is commonly reviewed alongside price movements to understand market activity.

Market Capitalisation and Share Information

Australian Clinical Labs Limited recorded a market capitalisation of $440.18M. Market capitalisation represents the total Market Value of a listed company’s shares based on its current share price and shares outstanding.

The company has 186,518,985 shares on issue, with ordinary fully paid shares listed on the Australian Securities Exchange.

The company’s International Securities Identification Number (ISIN) is AU0000148496.

Historical Trading Range

Australian Clinical Labs Limited shares recorded a 52-week trading range between $1.832 and $2.970.

The 52-week range provides a historical view of the highest and lowest prices reached by the stock over the previous year. This metric is commonly used to understand the movement of a company’s share price over different market conditions.

The stock’s trading activity reflects changes in market participation and can be influenced by company updates, sector movements and broader market conditions.

Healthcare Equipment and Services Sector

Australian Clinical Labs Limited is classified within the health care equipment and services industry group. This sector includes companies involved in healthcare-related products, services and solutions.

Companies within the healthcare sector can experience changes in market performance based on industry trends, operational developments, regulatory environments and broader economic conditions.

For listed healthcare companies, Market Participants commonly review indicators such as share price movements, trading volume, market capitalisation and company disclosures.

Listing History and Market Information

Australian Clinical Labs Limited was listed on the Australian Securities Exchange on 14 May 2021.

The company’s ordinary fully paid shares trade under the ticker code ASX:ACL. Its market profile includes daily trading activity, share price performance, historical trading range and market capitalisation.

These indicators provide a snapshot of the company’s position within the Australian listed Equity market and help track changes in trading patterns over time.

Understanding ASX Market Indicators

Market indicators such as share price, trading volume, market capitalisation and historical price ranges are commonly used to review listed securities.

A share price reflects the value at which buyers and sellers are trading a security at a particular time. Trading volume indicates market participation, while market capitalisation provides context on the company’s size within the listed market.

These indicators represent market activity and should be considered alongside company reports, announcements and financial disclosures for a broader understanding of a business.

Conclusion

Australian Clinical Labs Limited (ASX:ACL) recorded a share price of $2.410, with a daily increase of 2.118% and trading volume of 468,347 shares. The company recorded a market capitalisation of $440.18M and operates within the health care equipment and services industry group. With a 52-week trading range of $1.832 to $2.970, ACL’s market activity reflects movements in its listed shares within the Australian equity market. This article provides an educational overview of available market information and does not constitute financial advice or Investment recommendations.

FAQs

Q: What is the ASX ticker code for Australian Clinical Labs Limited?

A:Australian Clinical Labs Limited is listed on the Australian Securities Exchange under the ticker code ASX:ACL.

Q: What was Australian Clinical Labs Limited’s latest share price?

A:Australian Clinical Labs Limited shares were trading at $2.410.

Q: What was the daily share price movement for ASX:ACL?

A:The company recorded a daily share price increase of 2.118%.

Q: What is Australian Clinical Labs Limited’s market capitalisation?

A:Australian Clinical Labs Limited recorded a market capitalisation of $440.18M.

Q: Which industry group does Australian Clinical Labs Limited belong to?

A:Australian Clinical Labs Limited belongs to the health care equipment and services industry group.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.